Note 8 - Accrued Liabilities

6 Months Ended

Dec. 31, 2024

Notes to Financial Statements

Accrued Liabilities [Text Block]

Note 8 - Accrued Liabilities

Accrued liabilities consist of the following:

	December 31,		June 30,
	2024		2024
	(in thousands)
Accrued savings offers	$	14,507	$	11,054
Accrued program liabilities		7,021		9,964
Accrued customer and product related fees		5,735		5,395
Return reserve		5,111		4,832
Accrued employee compensation		3,971		4,603
Other accrued liabilities		3,027		2,295
Total accrued liabilities	$	39,372	$	38,143

Accrued savings offers represent programs for the Company’s patients covered under commercial payor plans in which the cost of a prescription to such patients is discounted. Accrued program liabilities include government and commercial rebates. Accrued customer and product related fees include accrued expenses and deductions for rebates, wholesaler chargebacks and fees, and other product-related fees and deductions such as royalties for Pediatric Portfolio products, accrued distributor fees, and Medicaid liabilities. The return reserve represents the Company’s accrual for estimated product returns. Accrued employee compensation includes sales commissions, paid time off earned, accrued payroll and accrued bonus. Other accrued liabilities consist of various other accruals, none of which individually or in the aggregate represent greater than five percent of total liabilities.